 | • レポートコード：GIR-2104Z06529 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、顆粒球-コロニー刺激因子のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。顆粒球-コロニー刺激因子の種類別市場規模（カプセル、錠剤、その他）、用途別市場規模（腫瘍性疾患、血液疾患、成長ホルモン欠乏症、慢性・自己免疫疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・顆粒球-コロニー刺激因子の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：BioCad、Dong-A Socio Group、Pfizer、Intas Pharmaceuticals、Novartis AG、Stada Arzneimittel、Teva Pharmaceutical Industries、Amgen、Dr. Reddy's Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：カプセル、錠剤、その他 ・用途別分析2016年-2026年：腫瘍性疾患、血液疾患、成長ホルモン欠乏症、慢性・自己免疫疾患、その他 ・顆粒球-コロニー刺激因子の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・顆粒球-コロニー刺激因子のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・顆粒球-コロニー刺激因子のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・顆粒球-コロニー刺激因子の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・顆粒球-コロニー刺激因子の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Granulocyte-Colony Stimulating Factor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Granulocyte-Colony Stimulating Factor size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Granulocyte-Colony Stimulating Factor market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Granulocyte-Colony Stimulating Factor market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsules
Tablets
Others
Market segment by Application can be divided into
Oncological Diseases
Blood Disorders
Growth Hormone Deficiencies
Chronic and Autoimmune Disorders
Others
The key market players for global Granulocyte-Colony Stimulating Factor market are listed below:
BioCad
Dong-A Socio Group
Pfizer
Intas Pharmaceuticals
Novartis AG
Stada Arzneimittel
Teva Pharmaceutical Industries
Amgen
Dr. Reddy’s Laboratories
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Granulocyte-Colony Stimulating Factor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Granulocyte-Colony Stimulating Factor Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Capsules
1.2.3 Tablets
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Granulocyte-Colony Stimulating Factor Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncological Diseases
1.3.3 Blood Disorders
1.3.4 Growth Hormone Deficiencies
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Global Granulocyte-Colony Stimulating Factor Market Size & Forecast
1.4.1 Global Granulocyte-Colony Stimulating Factor Sales in Value (2016-2026))
1.4.2 Global Granulocyte-Colony Stimulating Factor Sales in Volume (2016-2026)
1.4.3 Global Granulocyte-Colony Stimulating Factor Price by Type (2016-2026) & (US$/Unit)
1.5 Global Granulocyte-Colony Stimulating Factor Production Capacity Analysis
1.5.1 Global Granulocyte-Colony Stimulating Factor Total Production Capacity (2016-2026)
1.5.2 Global Granulocyte-Colony Stimulating Factor Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Granulocyte-Colony Stimulating Factor Market Drivers
1.6.2 Granulocyte-Colony Stimulating Factor Market Restraints
1.6.3 Granulocyte-Colony Stimulating Factor Trends Analysis
2 Manufacturers Profiles
2.1 BioCad
2.1.1 BioCad Details
2.1.2 BioCad Major Business
2.1.3 BioCad Granulocyte-Colony Stimulating Factor Product and Services
2.1.4 BioCad Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Dong-A Socio Group
2.2.1 Dong-A Socio Group Details
2.2.2 Dong-A Socio Group Major Business
2.2.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Product and Services
2.2.4 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Granulocyte-Colony Stimulating Factor Product and Services
2.3.4 Pfizer Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Intas Pharmaceuticals
2.4.1 Intas Pharmaceuticals Details
2.4.2 Intas Pharmaceuticals Major Business
2.4.3 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Product and Services
2.4.4 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Granulocyte-Colony Stimulating Factor Product and Services
2.5.4 Novartis AG Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Stada Arzneimittel
2.6.1 Stada Arzneimittel Details
2.6.2 Stada Arzneimittel Major Business
2.6.3 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Product and Services
2.6.4 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business
2.7.3 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Product and Services
2.7.4 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Granulocyte-Colony Stimulating Factor Product and Services
2.8.4 Amgen Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Dr. Reddy’s Laboratories
2.9.1 Dr. Reddy’s Laboratories Details
2.9.2 Dr. Reddy’s Laboratories Major Business
2.9.3 Dr. Reddy’s Laboratories Granulocyte-Colony Stimulating Factor Product and Services
2.9.4 Dr. Reddy’s Laboratories Granulocyte-Colony Stimulating Factor Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Granulocyte-Colony Stimulating Factor Sales by Manufacturer
3.1 Global Granulocyte-Colony Stimulating Factor Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Granulocyte-Colony Stimulating Factor Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Granulocyte-Colony Stimulating Factor
3.4 Market Concentration Rate
3.4.1 Top 3 Granulocyte-Colony Stimulating Factor Manufacturer Market Share
3.4.2 Top 6 Granulocyte-Colony Stimulating Factor Manufacturer Market Share
3.5 Global Granulocyte-Colony Stimulating Factor Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Granulocyte-Colony Stimulating Factor Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Granulocyte-Colony Stimulating Factor Market Size by Region
4.1.1 Global Granulocyte-Colony Stimulating Factor Sales in Volume by Region (2016-2026)
4.1.2 Global Granulocyte-Colony Stimulating Factor Revenue by Region (2016-2026)
4.2 North America Granulocyte-Colony Stimulating Factor Revenue (2016-2026)
4.3 Europe Granulocyte-Colony Stimulating Factor Revenue (2016-2026)
4.4 Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue (2016-2026)
4.5 South America Granulocyte-Colony Stimulating Factor Revenue (2016-2026)
4.6 Middle East and Africa Granulocyte-Colony Stimulating Factor Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Granulocyte-Colony Stimulating Factor Sales in Volume by Type (2016-2026)
5.2 Global Granulocyte-Colony Stimulating Factor Revenue by Type (2016-2026)
5.3 Global Granulocyte-Colony Stimulating Factor Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Granulocyte-Colony Stimulating Factor Sales in Volume by Application (2016-2026)
6.2 Global Granulocyte-Colony Stimulating Factor Revenue by Application (2016-2026)
6.3 Global Granulocyte-Colony Stimulating Factor Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Granulocyte-Colony Stimulating Factor Sales by Type (2016-2026)
7.2 North America Granulocyte-Colony Stimulating Factor Sales by Application (2016-2026)
7.3 North America Granulocyte-Colony Stimulating Factor Market Size by Country
7.3.1 North America Granulocyte-Colony Stimulating Factor Sales in Volume by Country (2016-2026)
7.3.2 North America Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Granulocyte-Colony Stimulating Factor Sales by Type (2016-2026)
8.2 Europe Granulocyte-Colony Stimulating Factor Sales by Application (2016-2026)
8.3 Europe Granulocyte-Colony Stimulating Factor Market Size by Country
8.3.1 Europe Granulocyte-Colony Stimulating Factor Sales in Volume by Country (2016-2026)
8.3.2 Europe Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Type (2016-2026)
9.2 Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Application (2016-2026)
9.3 Asia-Pacific Granulocyte-Colony Stimulating Factor Market Size by Region
9.3.1 Asia-Pacific Granulocyte-Colony Stimulating Factor Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Granulocyte-Colony Stimulating Factor Sales by Type (2016-2026)
10.2 South America Granulocyte-Colony Stimulating Factor Sales by Application (2016-2026)
10.3 South America Granulocyte-Colony Stimulating Factor Market Size by Country
10.3.1 South America Granulocyte-Colony Stimulating Factor Sales in Volume by Country (2016-2026)
10.3.2 South America Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Type (2016-2026)
11.2 Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Application (2016-2026)
11.3 Middle East & Africa Granulocyte-Colony Stimulating Factor Market Size by Country
11.3.1 Middle East & Africa Granulocyte-Colony Stimulating Factor Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Granulocyte-Colony Stimulating Factor Typical Distributors
12.3 Granulocyte-Colony Stimulating Factor Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Granulocyte-Colony Stimulating Factor Revenue by Type, (USD Million), 2021-2026
Table 2. Global Granulocyte-Colony Stimulating Factor Revenue by Application, (USD Million), 2021-2026
Table 3. BioCad Basic Information, Manufacturing Base and Competitors
Table 4. BioCad Major Business
Table 5. BioCad Granulocyte-Colony Stimulating Factor Product and Services
Table 6. BioCad Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Dong-A Socio Group Basic Information, Manufacturing Base and Competitors
Table 8. Dong-A Socio Group Major Business
Table 9. Dong-A Socio Group Granulocyte-Colony Stimulating Factor Product and Services
Table 10. Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Granulocyte-Colony Stimulating Factor Product and Services
Table 14. Pfizer Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Intas Pharmaceuticals Major Business
Table 17. Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Product and Services
Table 18. Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 20. Novartis AG Major Business
Table 21. Novartis AG Granulocyte-Colony Stimulating Factor Product and Services
Table 22. Novartis AG Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 24. Stada Arzneimittel Major Business
Table 25. Stada Arzneimittel Granulocyte-Colony Stimulating Factor Product and Services
Table 26. Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical Industries Major Business
Table 29. Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Product and Services
Table 30. Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Amgen Basic Information, Manufacturing Base and Competitors
Table 32. Amgen Major Business
Table 33. Amgen Granulocyte-Colony Stimulating Factor Product and Services
Table 34. Amgen Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr. Reddy's Laboratories Major Business
Table 37. Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Product and Services
Table 38. Dr. Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Granulocyte-Colony Stimulating Factor Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Granulocyte-Colony Stimulating Factor Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Granulocyte-Colony Stimulating Factor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Granulocyte-Colony Stimulating Factor Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Granulocyte-Colony Stimulating Factor Production Site of Key Manufacturer
Table 44. Global Granulocyte-Colony Stimulating Factor Sales by Region (2016-2021e) & (K Units)
Table 45. Global Granulocyte-Colony Stimulating Factor Sales by Region (2021-2026) & (K Units)
Table 46. Global Granulocyte-Colony Stimulating Factor Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Granulocyte-Colony Stimulating Factor Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Granulocyte-Colony Stimulating Factor Sales by Type (2016-2021e) & (K Units)
Table 49. Global Granulocyte-Colony Stimulating Factor Sales by Type (2021-2026) & (K Units)
Table 50. Global Granulocyte-Colony Stimulating Factor Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Granulocyte-Colony Stimulating Factor Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Granulocyte-Colony Stimulating Factor Price by Type (2016-2021e) & (US$/Unit)
Table 53. Global Granulocyte-Colony Stimulating Factor Price by Type (2021-2026) & (US$/Unit)
Table 54. Global Granulocyte-Colony Stimulating Factor Sales by Application (2016-2021e) & (K Units)
Table 55. Global Granulocyte-Colony Stimulating Factor Sales by Application (2021-2026) & (K Units)
Table 56. Global Granulocyte-Colony Stimulating Factor Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Granulocyte-Colony Stimulating Factor Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Granulocyte-Colony Stimulating Factor Price by Application (2016-2021e) & (US$/Unit)
Table 59. Global Granulocyte-Colony Stimulating Factor Price by Application (2021-2026) & (US$/Unit)
Table 60. North America Granulocyte-Colony Stimulating Factor Sales by Country (2016-2021e) & (K Units)
Table 61. North America Granulocyte-Colony Stimulating Factor Sales by Country (2021-2026) & (K Units)
Table 62. North America Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Granulocyte-Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Granulocyte-Colony Stimulating Factor Sales by Type (2016-2021e) & (K Units)
Table 65. North America Granulocyte-Colony Stimulating Factor Sales by Type (2021-2026) & (K Units)
Table 66. North America Granulocyte-Colony Stimulating Factor Sales by Application (2016-2021e) & (K Units)
Table 67. North America Granulocyte-Colony Stimulating Factor Sales by Application (2021-2026) & (K Units)
Table 68. Europe Granulocyte-Colony Stimulating Factor Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Granulocyte-Colony Stimulating Factor Sales by Country (2021-2026) & (K Units)
Table 70. Europe Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Granulocyte-Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Granulocyte-Colony Stimulating Factor Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Granulocyte-Colony Stimulating Factor Sales by Type (2021-2026) & (K Units)
Table 74. Europe Granulocyte-Colony Stimulating Factor Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Granulocyte-Colony Stimulating Factor Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales by Application (2021-2026) & (K Units)
Table 84. South America Granulocyte-Colony Stimulating Factor Sales by Country (2016-2021e) & (K Units)
Table 85. South America Granulocyte-Colony Stimulating Factor Sales by Country (2021-2026) & (K Units)
Table 86. South America Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Granulocyte-Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Granulocyte-Colony Stimulating Factor Sales by Type (2016-2021e) & (K Units)
Table 89. South America Granulocyte-Colony Stimulating Factor Sales by Type (2021-2026) & (K Units)
Table 90. South America Granulocyte-Colony Stimulating Factor Sales by Application (2016-2021e) & (K Units)
Table 91. South America Granulocyte-Colony Stimulating Factor Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Granulocyte-Colony Stimulating Factor Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Granulocyte-Colony Stimulating Factor Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Granulocyte-Colony Stimulating Factor Typical Distributors
Table 103. Granulocyte-Colony Stimulating Factor Typical Customers
List of Figures
Figure 1. Granulocyte-Colony Stimulating Factor Picture
Figure 2. Global Granulocyte-Colony Stimulating Factor Sales Market Share by Type in 2020
Figure 3. Capsules
Figure 4. Tablets
Figure 5. Others
Figure 6. Global Granulocyte-Colony Stimulating Factor Sales Market Share by Application in 2020
Figure 7. Oncological Diseases
Figure 8. Blood Disorders
Figure 9. Growth Hormone Deficiencies
Figure 10. Chronic and Autoimmune Disorders
Figure 11. Others
Figure 12. Global Granulocyte-Colony Stimulating Factor Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Granulocyte-Colony Stimulating Factor Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Granulocyte-Colony Stimulating Factor Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Granulocyte-Colony Stimulating Factor Sales (2016-2026) & (K Units)
Figure 34. Global Granulocyte-Colony Stimulating Factor Production Capacity (2016-2026) & (K Units)
Figure 35. Global Granulocyte-Colony Stimulating Factor Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Granulocyte-Colony Stimulating Factor Market Drivers
Figure 37. Granulocyte-Colony Stimulating Factor Market Restraints
Figure 38. Granulocyte-Colony Stimulating Factor Market Trends
Figure 39. Global Granulocyte-Colony Stimulating Factor Sales Market Share by Manufacturer in 2020
Figure 40. Global Granulocyte-Colony Stimulating Factor Revenue Market Share by Manufacturer in 2020
Figure 41. Granulocyte-Colony Stimulating Factor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Granulocyte-Colony Stimulating Factor Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Granulocyte-Colony Stimulating Factor Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Granulocyte-Colony Stimulating Factor Sales Market Share by Region (2016-2026)
Figure 45. Global Granulocyte-Colony Stimulating Factor Revenue Market Share by Region (2016-2026)
Figure 46. North America Granulocyte-Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 47. Europe Granulocyte-Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 49. South America Granulocyte-Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Granulocyte-Colony Stimulating Factor Revenue (2016-2026) & (USD Million)
Figure 51. Global Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 52. Global Granulocyte-Colony Stimulating Factor Revenue Market Share by Type (2016-2026)
Figure 53. Global Granulocyte-Colony Stimulating Factor Price by Type (2016-2026) & (US$/Unit)
Figure 54. Global Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 55. Global Granulocyte-Colony Stimulating Factor Revenue Market Share by Application (2016-2026)
Figure 56. Global Granulocyte-Colony Stimulating Factor Price by Application (2016-2026) & (US$/Unit)
Figure 57. North America Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 58. North America Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 59. North America Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 60. North America Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 61. Europe Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 62. Europe Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 63. Europe Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 64. Europe Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Granulocyte-Colony Stimulating Factor Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 69. South America Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 70. South America Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 71. South America Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 72. South America Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Granulocyte-Colony Stimulating Factor Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Granulocyte-Colony Stimulating Factor Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年） Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A. Market Analysi…- 世界のバイオシミラー/フォローオンバイオロジクス市場規模・現状・予測（2021年-2027年） Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. Market Analysis and Insights: Global …
- 世界の自動コロニーカウンター市場 2021：企業別、地域別、種類・用途別 The Automated Colony Counter market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の自動コロニーカウンター市場 2021：企業別、地域別、種類・用途別 The Automated Colony Counters market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界のエリスロポエチン刺激剤市場規模・現状・予測（2021年-2027年） Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. Market Analysis and Insights: Global Erythropoietin Stimulat…